Search results for Ponezumab
Ponezumab, Abbexa, abx831216
Ponezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta40, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Ponezumab Biosimilar - Research Grade, ichor.bio, ICH5111
Detects human APP
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Ponezumab (HP529016), abinScience, HP529016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.